Champions Oncology Inc
CSBR
Get informed when a big investor buys or sells
+ FollowMarket Cap$67.24M
Close$
$0.08
98.3% downside
Current Fair Value
98.3% downsideOvervalued by 98.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $67.24 Million |
|---|---|
| Enterprise Value | $92.85 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.08 |
| Beta | 0.43 |
| Outstanding Shares | 13,897,535 |
Return
| Return on Equity | -29.15% |
|---|---|
| Return on Assets | -3.41% |
| Return on Invested Capital | -10.35% |
Valuation & Multiples
| P/E Ratio | -61.27 |
|---|---|
| PEG | 713.75 |
| Price to Sales | 1.6 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.11 |
| Enterprise Value to EBIT | -61.61 |
| Enterprise Value to Net Income | -82 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 7.7 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 16, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$15.04 M
Average shareholder expectationNext Earnings Call
Expected Date
December 15, 2026
EPS Estimate
$0.02
Average shareholder expectationRevenue Estimate
$16.37 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 42.58%▲ 1.13% |
|---|---|
| Total Invested | $36.28M▲ 10.06% |
| Investors Holding | 27▲ 2.00% |
ESG Score
No data
About Champions Oncology Inc
143 employeesChampions Oncology is a data-driven research organization that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computa...